Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms

Research output: Contribution to journalArticle

44 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)844-846
Number of pages3
JournalNew England Journal of Medicine
Volume366
Issue number9
DOIs
StatePublished - Mar 1 2012

Fingerprint

Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms. / Tefferi, Ayalew.

In: New England Journal of Medicine, Vol. 366, No. 9, 01.03.2012, p. 844-846.

Research output: Contribution to journalArticle

@article{9262c7cbc88b4c159bbab348c70a6f5b,
title = "Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms",
author = "Ayalew Tefferi",
year = "2012",
month = "3",
day = "1",
doi = "10.1056/NEJMe1115119",
language = "English (US)",
volume = "366",
pages = "844--846",
journal = "New England Journal of Medicine",
issn = "1533-4406",
publisher = "Massachussetts Medical Society",
number = "9",

}

TY - JOUR

T1 - Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms

AU - Tefferi, Ayalew

PY - 2012/3/1

Y1 - 2012/3/1

UR - http://www.scopus.com/inward/record.url?scp=84857828112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857828112&partnerID=8YFLogxK

U2 - 10.1056/NEJMe1115119

DO - 10.1056/NEJMe1115119

M3 - Article

VL - 366

SP - 844

EP - 846

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 1533-4406

IS - 9

ER -